Editorial Comment
Is an Implantable Cardiac Monitor the Standard of Care for Determining the Success of Atrial Fibrillation Ablation?
JASON G. ANDRADE M.D.,
ANDREW D. KRAHN M.D.,
Corresponding Author
JASON G. ANDRADE M.D.
Division of Cardiology, Department of Medicine, the University of British Columbia, Vancouver, Canada
the Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada
Address for correspondence: Dr. Jason G. Andrade, M.D., Division of Cardiology, Department of Medicine, The University of British Columbia, Room 9169, 9th Floor, 2775 Laurel St., Vancouver, BC V6N 3S9, Canada. Fax: 604-875-5874; E-mail: [email protected]Search for more papers by this authorANDREW D. KRAHN M.D.
Division of Cardiology, Department of Medicine, the University of British Columbia, Vancouver, Canada
Search for more papers by this authorJASON G. ANDRADE M.D.,
ANDREW D. KRAHN M.D.,
Corresponding Author
JASON G. ANDRADE M.D.
Division of Cardiology, Department of Medicine, the University of British Columbia, Vancouver, Canada
the Electrophysiology Service at the Montreal Heart Institute and the Department of Medicine, Université de Montréal, Montreal, Canada
Address for correspondence: Dr. Jason G. Andrade, M.D., Division of Cardiology, Department of Medicine, The University of British Columbia, Room 9169, 9th Floor, 2775 Laurel St., Vancouver, BC V6N 3S9, Canada. Fax: 604-875-5874; E-mail: [email protected]Search for more papers by this authorANDREW D. KRAHN M.D.
Division of Cardiology, Department of Medicine, the University of British Columbia, Vancouver, Canada
Search for more papers by this authorDr. Krahn is a consultant for Medtronic.
References
- 1Gillis AM, Verma A, Talajic M, Nattel S, Dorian P: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Rate and rhythm management. Can J Cardiol 2011; 27: 47-59.
- 2Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 2000; 342: 913-920.
- 3Singh SN, Singh BN, Reda DJ, Fye CL, Ezekowitz MD, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD Jr, Antman EM, Falk RH, Lopez B, Tang XC: Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone fibrillation efficacy trial [Safe-T]). Am J Cardiol 2003; 92: 468-472.
- 4Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I: Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2: 349-361.
- 5Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D: 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012; 9: 632-696, e621.
- 6Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo CA, Khaykin Y, Birnie D: Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): A prospective, multicenter study. JAMA Inter Med 2013; 173: 149-156.
- 7Kottkamp H, Tanner H, Kobza R, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, Piorkowski C, Hindricks G: Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: Trigger elimination or substrate modification: Early or delayed cure? J Am Coll Cardiol 2004; 44: 869-877.
- 8Piorkowski C, Kottkamp H, Tanner H, Kobza R, Nielsen JC, Arya A, Hindricks G: Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16: 1286-1292.
- 9Ziegler PD, Koehler JL, Mehra R: Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006; 3: 1445-1452.
- 10Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck KH, Lebedev D, Rieger G, Purerfellner H, Investigators XT: Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ Arrhythm Electrophysiol 2010; 3: 141-147.
- 11Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD: The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study. Circ Arrhythm Electrophysiol 2009; 2: 474-480.
- 12Zimetbaum P, Goldman A: Ambulatory arrhythmia monitoring: Choosing the right device. Circulation 2010; 122: 1629-1636.
- 13Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ: Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013; 80: 1546-1550.
- 14Pedrote A, Arana-Rueda E, Garcia-Riesco L, Sanchez-Brotons J, Duran-Guerrero M, Gomez-Pulido F, Arce-Leon A, Frutos-Lopez M: Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: An observational study through a subcutaneous leadless cardiac monitor. J Cardiovasc Electrophysiol 2013; 24: 1075-1082.
- 15Holter NJ: Radioelectrocardiography: A new technique for cardiovascular studies. Ann N Y Acad Sci 1957; 65: 913-923.
Citing Literature
